Effect of MET on Meralgia Paraesthesia Postpartum "Muscle Energy Technique" (MET)

The Effect of Muscle Energy Technique on Femoral Meralgia Paraesthesia in Postpartum: A Randomized Controlled Trial

To investigate the effect of muscle energy technique on Femoral meralgia paraesthesia in a postpartum female. BACKGROUND: meralgia paraesthesia is one of the serious disorders in the postpartum female which results in pain and less physical activities.

………HYPOTHESES:

This study hypothesized that:

muscle energy technique will have a significant effect on Femoral meralgia paraesthesia in postpartum female

Study Overview

• Status: Completed
• Conditions: Femoral Neuropathy; Meralgia Paresthetica
• Intervention / Treatment: Other: muscle energy technique; Other: conventional selected physical therapy

Detailed Description

Thirty meralgia paraesthesia postpartum females will participate in this study.

The patients will randomly be divided into two equal groups; the control group received the conventional selected exercise program and the study group received the same exercise training program in addition to muscle energy technique, three times per week for four weeks.

The evaluation methods by Femoral nerve conduction velocity will be measured via the Neuropack S1 MEB9004 EMG device before the exercise program and after finishing the exercise program, and also the Pelvic compression test and Pain numeric rating scale

• Study Type: Interventional
• Enrollment (Actual): 30
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Egypt
  • Select State
    • Al Jīzah, Select State, Egypt
      • Lama S Mahmoud

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 21 years to 36 years (Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: Female

Description

Inclusion Criteria:

• Thirty meralgia paraesthesia postpartum female Patients
• with positive Pelvic compression test
• age ranging from 25:40 years
• post vaginal delivery or post-operative (postpartum) persistent dysthesia in anterolateral thigh (one side or both)
• body mass index (20:29.9) Kg/m2

Exclusion Criteria:

• difficulty to communicate or to understand program instructions
• other conditions that caused pain (for example fibromyalgia and arthritis)
• any psychiatric or cognitive symptoms any other musculoskeletal disorders or neurologic diseases of the lower extremities and spine

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: study group; received the conventional selected exercise program in addition to muscle energy technique	Other: muscle energy technique; the patient was supine and the therapist fix the lower limb of the affected side then ask the patient to perform isometric contraction for abductors maintained for 3-5 seconds, then the patient was instructed to stop, exhale and relax then the therapist perform further adducted the patient's knee of the affected side as a stretching exercise for Three to five repetitions of these directions were performed.; Other: conventional selected physical therapy; life style modification; Transcutaneous electrical nerve stimulation (TENS); Flexibility stretching exercises to the hip flexors
Experimental: control group; received the conventional selected exercise program	Other: conventional selected physical therapy; life style modification; Transcutaneous electrical nerve stimulation (TENS); Flexibility stretching exercises to the hip flexors

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Femoral nerve conduction latency	Femoral nerve conduction latency measured via the Neuropack S1 MEB9004 EMG device	4 weeks

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Pelvic compression test	the therapist applied a downward compression force to the pelvis and maintained a pressure for 45 seconds. If the patients reported an alleviation of symptoms the test is considered positive	four weeks
Numeric Pain Rating Scale (NPRS)	it includes 11-point numeric scale ranges from no pain with score of "0" to worst pain imaginable with score of "10"	four weeks

Collaborators and Investigators

• Sponsor: October 6 University
• Investigators: Study Chair: Lama Saad Mahmoud, PHD, October 6 University

Study record dates

Study Major Dates

• Study Start (Actual): October 1, 2020
• Primary Completion (Actual): December 30, 2020
• Study Completion (Actual): January 30, 2021

Study Registration Dates

• First Submitted: February 6, 2021
• First Submitted That Met QC Criteria: February 9, 2021
• First Posted (Actual): February 10, 2021

Study Record Updates

• Last Update Posted (Actual): February 10, 2021
• Last Update Submitted That Met QC Criteria: February 9, 2021
• Last Verified: February 1, 2021

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Nervous System Diseases; Neurologic Manifestations; Neuromuscular Diseases; Mononeuropathies; Peripheral Nervous System Diseases; Sensation Disorders; Somatosensory Disorders; Paresthesia; Femoral Neuropathy
• Other Study ID Numbers: P.T. REC/012/002864

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No